Posts Tagged ‘drug importation’
Head of Patient Advocacy Organization Warns That Drug Importation Is Not The Solution American Patients Need
In this editorial by Terry Wilcox published in Inside Sources on April 18, 2019, Terry Wilcox, executive director of a patient advocacy organization advices federal and state representatives that allowing drug importation is not the right policy solution for America’s high prescription drug prices…
[...]Tampa Pharmacist Speaks Out Against Florida’s Drug Importation Proposal
This editorial by Dan Fucarino was published in Florida Politics on April 1, 2019. Mr Fucarino is the owner and a pharmacist at Carrollwood Compounding Center & Pharmacy.
“The monetary rewards of Canadian prescriptions are just not worth their safety risks,” he warns. “I urge Florida legislators to listen to health care experts on this issue rather than the understandable populist appeals and vote no on this dangerous legislation — and then get back to working on more productive ways to lower drug prices for Floridians. Thousands of Americans have been injured or killed by imported prescription drugs.”
[...]Drug Importation Claim vs. Fact At Florida Senate Subcommittee Hearing
Experts and leadership from The Partnership for Safe Medicines were in Tallahassee, Florida on Monday, March 25th for a Senate hearing on an ill-advised Canadian drug importation bill. During the hearing, our team heard many false or misleading statements about the proposal to take medicine out of the Canadian medicine supply and ship it to Florida. Here’s a fact check of the most egregious ones…
[...]“Canadian Shelves Would Run Dry” Warns Canadian Health Economist about U.S. Proposals to Raid Canadian Drug Supply
Some politicians have suggested that allowing the importation of prescription drugs from Canada would be a safe and effective way to lower the cost of medications for Americans, but this idea overlooks a very important fact: the Canadian drug supply chain is not built to support Canada’s population and the United States’…
[...]PSM Went to Congress to Share Our Concerns About The Threat of Counterfeit Medicine
On Thursday, January 31, 2018, the Partnership for Safe Medicines held two briefings in Washington, D.C. to inform members of Congress and their staff about the dangers posed to Americans by counterfeit medicines. The events each had three panels and looked at how fake medicines have affected individuals and law enforcement, and also at the roles played by international bad actors and drug cartels…
[...]Drug Importation and the Deadly Challenge of Screening 275 Million Packages a Year
The Food and Drug Administration (FDA) in their report U.S. Food and Drug Administration and the International Mail Facilities (IMFs), describes the daunting job that Customs and Border Protection (CBP) faces when attempting to weed out counterfeit medications and packages containing illicit fentanyl. In 2017, IMFs received 275 million packages. Of these, 10,000 were screened by CBP, and of those 86% contained drugs. The investigation of a suspect package is incredibly time-consuming; an experienced FDA investigator might take as long as 20 minutes to process a package containing just on product.
[...]Chairman and Editor In Chief Warns That Allowing Drug Importation Is All Risk And No Reward
In this October 10, 2018 editorial for The Hill, publishing executive warns that America has nothing to gain and everything to lose if we forsake our secure drug supply chain for allowing the importation of dangerous drugs…
[...]Arizona Substance Abuse Coalition/FDA: ‘Know Your Source’ for Prescription Medication
Doug Herbert, a retired Drug Enforcement Agent and volunteer with the Arizona Substance Abuse Coalition spoke with Arizona’s Fountain Hills Times about the “elephant in the room” that is counterfeit drugs in America.
[...]President Of Nonprofit Warns That Allowing Foreign Drug Importation Is A Threat To U.S. Patients
In this September 17, 2018, editorial for The Detroit News, the Center for Medicine in the Public Interest’s President and co-founder Peter Pitts warned that legalizing prescription drug importation will not generate massive savings for U.S. citizens while also potentially exposing millions of Americans to dangerous counterfeit drugs…
[...]Importation Has Some Huge Risks
There are certainly things we can learn from other countries’ healthcare successes, but importation is not the right approach.
[...]